Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.0900 (-4.04%) ($3.0900 - $3.0900) on Wed. Feb. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.64% (three month average) | RSI | 44 | Latest Price | $3.0900(-4.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) IWO(84%) SKYY(83%) ARKG(82%) QQQ(82%) | Factors Impacting CGEN price | CGEN will decline at least -1.82% in a week (0% probabilities). VIXM(-75%) VXX(-56%) UUP(-31%) EDOC(-16%) GLD(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.82% (StdDev 3.64%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.72(-446.93%) | Resistance Level | $3.32 | 5 Day Moving Average | $3.12(-0.96%) | 10 Day Moving Average | $3.15(-1.9%) | 20 Day Moving Average | $3.32(-6.93%) | To recent high | -40.1% | To recent low | 2% | Market Cap | $256m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |